We are live on
!
Find out more
BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.97B
1-Year Est. Return
44.96%
This Fund
S&P 500
This Quarter
Est. Return
+5.04%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$9.85B
AUM Growth
+$544M
(+5.8%)
Cap. Flow
+$305M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
10.6%
Holding
1,507
New
131
Increased
296
Reduced
233
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$69.7M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$62.8M |
| 3 |
Extra Space Storage
EXR
|
+$62.1M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$58.4M |
| 5 |
Cigna
CI
|
+$58.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$70.2M |
| 2 |
Sempra
SRE
|
+$62.5M |
| 3 |
Lincoln National
LNC
|
+$62.2M |
| 4 |
XL
XL Group Ltd.
XL
|
+$60.6M |
| 5 |
NextEra Energy
NEE
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.55% |
| 2 | Industrials | 12.89% |
| 3 | Consumer Discretionary | 12.47% |
| 4 | Healthcare | 10.29% |
| 5 | Technology | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRZO
1151
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $479K | ﹤0.01% |
17,200
| – | – |
|
|
BLMT
1152
DELISTED
BSB Bancorp, Inc.
BLMT
| $478K | ﹤0.01% |
13,900
+5,500
| +65% | +$182K |
|
|
HF
1153
DELISTED
HFF Inc.
HF
| $477K | ﹤0.01% |
13,900
| – | – |
|
1154
National Health Investors
NHI
$3.72B
| $472K | ﹤0.01% |
6,400
| – | – |
|
1155
Full House Resorts
FLL
$80.1M
| $470K | ﹤0.01% |
141,000
| – | – |
|
1156
Aptevo Therapeutics
APVO
$5.12M
| – | – |
0
| – | – |
|
1157
The Ensign Group
ENSG
$10.4B
| $469K | ﹤0.01% |
+14,004
| New | +$432K |
|
|
IMI
1158
DELISTED
Intermolecular, Inc.
IMI
| $469K | ﹤0.01% |
280,700
+20,000
| +8% | +$27.3K |
|
1159
China Automotive Systems
CAAS
$136M
| $465K | ﹤0.01% |
106,700
-9,700
| -8% | -$42.2K |
|
|
TLGT
1160
DELISTED
Teligent, Inc
TLGT
| $460K | ﹤0.01% |
13,308
+2,598
| +24% | +$81.7K |
|
1161
Pro-Dex
PDEX
$187M
| $459K | ﹤0.01% |
68,500
-8,100
| -11% | -$54.2K |
|
|
UFAB
1162
DELISTED
Unique Fabricating, Inc.
UFAB
| $456K | ﹤0.01% |
52,200
+2,200
| +4% | +$19.9K |
|
1163
Savara
SVRA
$1.12B
| $453K | ﹤0.01% |
+40,000
| New | +$401K |
|
1164
Ardelyx
ARDX
$1.22B
| $448K | ﹤0.01% |
121,100
| – | – |
|
1165
Chicago Rivet & Machine Co
CVR
$10M
| $448K | ﹤0.01% |
13,900
| – | – |
|
1166
ACI Worldwide
ACIW
$5.83B
| $447K | ﹤0.01% |
+18,100
| New | +$441K |
|
1167
Lifeway Foods
LWAY
$455M
| $443K | ﹤0.01% |
88,052
-11,780
| -12% | -$66.2K |
|
1168
Quantum Corp
QMCO
$419M
| $441K | ﹤0.01% |
10,030
+2,102
| +27% | +$141K |
|
1169
Allient
ALNT
$1.49B
| $438K | ﹤0.01% |
13,725
-45,750
| -77% | -$1.37M |
|
1170
Colony Bankcorp
CBAN
$465M
| $437K | ﹤0.01% |
25,868
+1,000
| +4% | +$16.3K |
|
1171
Smith Micro Software
SMSI
$14.5M
| $435K | ﹤0.01% |
4,750
| – | – |
|
1172
American Vanguard Corp
AVD
$68.4M
| $434K | ﹤0.01% |
18,900
-35,300
| -65% | -$780K |
|
|
DXYN
1173
DELISTED
Dixie Group Inc
DXYN
| $433K | ﹤0.01% |
188,200
| – | – |
|
|
CCXI
1174
DELISTED
ChemoCentryx, Inc.
CCXI
| $433K | ﹤0.01% |
32,896
-17,350
| -35% | -$207K |
|
|
MXWL
1175
DELISTED
Maxwell Technologies Inc
MXWL
| $433K | ﹤0.01% |
83,200
| – | – |
|
Similar funds
CFC
SNT
MA
FFB
AM
SGM
PAMP
SMFG
Bridgeway Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Bridgeway Capital Management held 1,507 positions worth $9.85B, up 5.8% from $9.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Bridgeway Capital Management deployed $305M of net new capital in Q2 2018, opening 131 new positions and adding to 296 existing holdings. Its largest new stake was Morgan Stanley: 1,333,400 shares worth $63.2M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Lam Research, an estimated $70.2M trimmed.
- Bridgeway Capital Management's largest Q2 2018 buy was Morgan Stanley: 1,333,400 shares worth $63.2M.
- Bridgeway Capital Management added most to Cigna in Q2 2018, an estimated $58.3M increase.
- Bridgeway Capital Management's biggest Q2 2018 reduction was Lam Research, cutting an estimated $70.2M.
- Bridgeway Capital Management fully exited Sempra in Q2 2018, selling an estimated $62.5M.
- Bridgeway Capital Management's ten largest holdings make up 11% of its $9.85B portfolio in Q2 2018.
- Bridgeway Capital Management opened 131 new positions and closed 100 in Q2 2018.
- Bridgeway Capital Management's portfolio value rose 5.8% quarter-over-quarter to $9.85B.
Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.